3.0.0 6102 2022-02-08T23:16:10Z 2023-09-05T17:28:05Z House HR 2020-03-05 116 [Congressional Record Volume 166, Number 44 (Thursday, March 5, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. DEGETTE:H.R. 6102.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3[Page H1536]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-03-05T14:02:25Z VALID Act of 2020 116 3404 S 2020-03-05 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Identical bill CRS 2020-03-05 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-03-05 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-03-05 Introduced in House IntroReferral 1000 9 Library of Congress D000197 Rep. DeGette, Diana [D-CO-1] DIANA DEGETTE D CO 1 N B001275 Rep. Bucshon, Larry [R-IN-8] Larry Bucshon R IN 8 2020-03-05 True Health Administrative law and regulatory procedures Administrative remedies Advisory bodies Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Federal preemption Food and Drug Administration (FDA) Government information and archives Health technology, devices, supplies Licensing and registrations Medical tests and diagnostic methods Performance measurement User charges and fees Health 00 2020-03-05 Introduced in House 2021-09-08T15:19:56Z Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020

This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).

]]> VALID Act of 2020 Display Title VALID Act of 2020 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes. Introduced in House IH Short Title(s) as Introduced VALID Act of 2020 Introduced in House IH Short Title(s) as Introduced Verifying Accurate Leading-edge IVCT Development Act of 2020 Introduced in House IH Introduced in House 2020-03-05T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr6102ih/xml/BILLS-116hr6102ih.xml 2020-03-05 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.